-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Lowered to $80 at Guggenheim
-
-
-
-
-
-
-
FDA approves Ionis Pharma's therapy to treat rare genetic disorder
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 37c
-
-
-
-
-
-
-
Increasing unusual option volume: BCE EQPT MDY DOMO CC IONS ARKG FRMM TOI DINO
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Lowered to $90 at Barclays
-
-
-
-
-
-
-
Stifel: 'We expect IONS shares to trade lower today and ALNY shares to be volatile'
-
-
-
-
-
-
-
Wolfe: 'Arrowhead Q3 data in acute pancreatitis will be the next big event to readthrough to Ionis. We see 74% odds of IONS stock down, 26% odds up'
-
480,794 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


